Perrigo Strengthens In Europe With Sanofi Skin-Care Brands
Executive Summary
Perrigo is investing to grow its reinvigorated International consumer health business by acquiring three OTC skin-care brands from Sanofi.
You may also be interested in...
If Successful, HRA Pharma Acquisition Will Complete Perrigo’s Pivot Towards Self-Care
If its acquisition of France's HRA Pharma completes, Perrigo will have “enough growth in our back pocket for the next three to five years without making any further acquisitions,” says the firm’s UK & Ireland chief, Neil Lister, in an exclusive interview with HBW Insight.
Top 20 Consumer Health Deals 2020: Private Equity And OTC Exits Drive M&A
HBW Insight reveals the biggest consumer health deals of 2020, and identifies growing private equity investment, portfolio streamlining by major players and pharma firms exiting OTC as the major drivers of M&A activity.
Perrigo Exploring The CBD Opportunity
Perrigo doesn't want to miss out on the opportunity presented by CBD to offer consumers a new type of self-care product, according to the firm’s managing director, UK & Ireland, and International vice president, Neil Lister.